8-KEarnings & ResultsLeadership ChangesExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Financial Results (Jul 16, 2019)

Filed July 16, 2019For Securities:CAH

Summary

Cardinal Health Inc. (CAH) filed an 8-K on July 15, 2019, reporting an event on July 11, 2019. The key takeaway for investors is the company's affirmation of its fiscal year 2019 non-GAAP earnings per share guidance. The company expects to meet at least the midpoint of its previously communicated EPS range, providing a degree of certainty for the fiscal year ending June 30, 2019. This reaffirmation suggests that the company's operational performance is on track to meet expectations heading into the end of the fiscal year. Additionally, the filing disclosed a significant executive change: Jon L. Giacomin, Chief Executive Officer of the Medical Segment, will depart the company effective August 16, 2019. While the earnings guidance affirmation is a positive signal regarding financial performance, this executive departure may warrant investor attention as it involves a key leadership role within a major business segment. The company also furnished the related press release as an exhibit.

Key Highlights

  • 1Cardinal Health reaffirms its expectation to meet at least the midpoint of its fiscal year 2019 non-GAAP EPS guidance.
  • 2The affirmation of guidance suggests confidence in the company's financial performance for the fiscal year ended June 30, 2019.
  • 3Jon L. Giacomin, CEO of the Medical Segment, will be leaving the company.
  • 4Mr. Giacomin's departure is effective August 16, 2019.
  • 5The news release containing the guidance affirmation is furnished as an exhibit.
  • 6No specific financial results for the current period were detailed, only the guidance reaffirmation.

Frequently Asked Questions

The primary financial update is Cardinal Health's affirmation that it expects to meet at least the midpoint of its previously announced non-GAAP earnings per share guidance for the fiscal year ended June 30, 2019.

Yes, Jon L. Giacomin, the Chief Executive Officer of the Medical Segment, has notified the company of his departure, which will be effective August 16, 2019.

No, this 8-K filing primarily serves to reaffirm the company's full-year earnings per share guidance and announce an executive departure. It does not contain detailed financial results for the current reporting period; those are typically found in the earnings release furnished as an exhibit or in the subsequent 10-Q filing.

The news release, furnished as Exhibit 99.1, contains the details of the company's guidance reaffirmation and potentially other related commentary that investors should review for a more complete understanding of the company's current outlook.